Friday, April 26, 2024
Home > Mateon

Blockchain-Fueled Company Mateon Develops Phase 3 Clinical Drug Candidate, Against COVID-19 – OT-101

Blockchain company Mateon Therapeutics (OTCQB:MATN)  has delivered the requisite testing results to Golden Mountain Partners (GMP) confirming the applicability and potential use of OT-101 for the treatment of COVID-19.Amit Shah, CFO of Mateon stated:“I am excited about the potential use of OT-101 against COVID-19. I congratulate the Mateon team on

Read More

Blockchain-Fueled Company Mateon Report Positive Results For Multiple Covid-19 Drug Candidates

Sharing is caring!Created by the recent merger of TGF-beta RNA therapeutics developer Oncotelic and PoinTR – a cluster computer vision empowered blockchain company,  a new immuno-oncology company Mateon has been created. Mateon is dedicated to the development of first in class RNA therapeutics and is particularly focussing on the development

Read More

Blockchain and AI Technologies Combined to Battle Coronavirus – Covid-19 as Immuno-Oncology Company Mateon Partners with Meridian IT to Fast Track Drug Manufacturing

Sharing is caring!Immuno-oncology company that specialises in RNA therapeutics Mateon is teaming up with heavyweight development company  Meridian IT to branch into a novel application of AI neural networks and blockchain technologies that will ensure compliance with the FDA while ensuring ROI for manufacturers by slashing labour costs. But most

Read More